FDA Rebukes Kim Kardashian for Morning-Sickness Drug Ad on Instagram

But pharma marketer Diclegis wins big anyway

The Food and Drug Administration has issued a warning letter informing Kim Kardashian's ad partner—the morning-sickness medication Diclegis—that her Instagram post promoting the drug was a no-no. Kardashian is pregnant with her and husband Kanye West's second child and came down with morning sickness in recent weeks.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in